Benjamin J. Hindson - 26 Feb 2026 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Title: President and Chief Scientific Officer, Director
Signature
/s/ Randy Wu, as Attorney-in-Fact for Benjamin J. Hindson
Issuer symbol
TXG
Transactions as of
26 Feb 2026
Net transactions value
$0
Form type
4
Filing time
02 Mar 2026, 16:23:49 UTC
Previous filing
25 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hindson Benjamin J. Title: President and Chief Scientific Officer, Director 10X GENOMICS, INC., 6230 STONERIDGE MALL ROAD, PLEASANTON /s/ Randy Wu, as Attorney-in-Fact for Benjamin J. Hindson 02 Mar 2026 0001786391

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Award $0 +88,816 +21% $0.000000 513,595 26 Feb 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/12th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2026, subject to the Reporting Person continuing as a service provider through each such date.

Remarks:

Title: President and Chief Scientific Officer